Aclaris Therapeutics, Inc., announced the FDA approved ESKATA™ (hydrogen peroxide) topical solution, 40% (w/w) for the treatment of seborrheic keratoses

This content is restricted to site members. If you are an existing user, please log in. New users may register below.

New User Registration
 
 
 
 
 
 
 
 
 
* Please indicate that you agree to the Terms of Service
*Required field